Clinical inquiries. How do we evaluate a marginally low B12 level?
Cravens
David D
DD
Department of Family and Community Medicine, University of Missouri-Columbia School of Medicine, USA.
Nashelsky
Joan
J
Oh
Robert C
RC
D005069:Evaluation Studies as Topic; D019317:Evidence-Based Medicine; D005194:Family Practice; D005260:Female; D006710:Homocysteine / Q000097:blood; D006801:Humans; D008297:Male; D008764:Methylmalonic Acid / Q000097:blood; D011379:Prognosis; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014805:Vitamin B 12 / Q000097:blood* / Q000627:therapeutic use; D014806:Vitamin B 12 Deficiency / Q000175:diagnosis* / Q000188:drug therapy*
D006710:Homocysteine; D008764:Methylmalonic Acid; D014805:Vitamin B 12